FPR1 and acute basophilic leukemia: RERF inhibits in a dose-dependent manner the directional migration of rat basophilic leukemia RBL-2H3/ETFR cells expressing high levels of FPR137 by preventing the uPAR/FPR1 interaction and, consequently, agonist-triggered FPR1 activation38.